1. Home
  2. BODI vs MCRB Comparison

BODI vs MCRB Comparison

Compare BODI & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

HOLD

Current Price

$10.13

Market Cap

75.4M

Sector

Industrials

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$7.71

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BODI
MCRB
Founded
1998
2010
Country
United States
United States
Employees
270
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.4M
71.0M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
BODI
MCRB
Price
$10.13
$7.71
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$15.00
$14.00
AVG Volume (30 Days)
25.8K
107.2K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$789,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$20.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.76
$5.31
52 Week High
$16.87
$29.98

Technical Indicators

Market Signals
Indicator
BODI
MCRB
Relative Strength Index (RSI) 49.94 57.98
Support Level $9.42 $6.56
Resistance Level $11.11 $9.53
Average True Range (ATR) 0.75 0.62
MACD 0.23 0.19
Stochastic Oscillator 69.52 85.45

Price Performance

Historical Comparison
BODI
MCRB

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: